Sizi C serves as a Product Partner at FoundersX Ventures, where she plays a pivotal role in identifying and nurturing early-stage companies that are at the forefront of AI transformation and digital infrastructure development. With a keen eye for innovation, Sizi focuses on investments that...
Sizi C serves as a Product Partner at FoundersX Ventures, where she plays a pivotal role in identifying and nurturing early-stage companies that are at the forefront of AI transformation and digital infrastructure development. With a keen eye for innovation, Sizi focuses on investments that prioritize product-market fit, robustness, and efficiency, particularly in sectors that are ripe for disruption. Her expertise lies in evaluating AI applications, biotech platforms, and transformative technologies, with a special emphasis on neuroscience and mental health solutions.
One of Sizi's key projects includes her involvement with Cognito Therapeutics, a groundbreaking company that is developing non-invasive therapeutics for neurodegenerative diseases, including Alzheimer's. Under her guidance, FoundersX Ventures led the Series B investment round, collaborating with esteemed partners such as Morningside and the Alzheimer's Drug Discovery Foundation. This pivotal trial not only showcases Sizi's commitment to advancing healthcare through innovative technology but also highlights her ability to identify high-potential startups that align with her vision for impactful change.
Additionally, Sizi is actively engaged with Solve Intelligence, an AI co-pilot platform that aims to revolutionize decision-making processes across various industries. Her strategic insights and investment acumen are instrumental in propelling these companies toward achieving their milestones while ensuring that they remain aligned with market needs and technological advancements. Through her work at FoundersX Ventures, Sizi C exemplifies the intersection of investment strategy and product development, driving forward the next wave of AI-driven solutions that promise to reshape our world.
